← SynDRA
A61603
SynDRA canonical compound SYN1954845 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ADRA1A |
| Mechanism of action | adrenergic receptor agonist |
All known targets
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2C
Mechanisms of action (all sources)
- adrenergic receptor agonist
- ADRA2C AGONIST
Cross-references
Synonyms
- A 61603
- N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide
- CHEMBL109783
- A61603;A-61603
- N-(5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)methanesulfonamide
- GTPL480
- SCHEMBL8856920
- CHEBI:103854
- BDBM50118703
- NCGC00024968-02
- L000090
- BRD-A83650191-004-01-0
- Q27074075
- Methanesulfonamide,N-[5-(4,5-dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]-,hydrobromide(1:1)
- N-[[5-[(4,5-Dihydro-1H-imidazol)-2-yl]-2-hydroxy-5,6,7,8-tetrahydronaphthalen]-1-yl]methanesulfonamide
- N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yl]-methanesulfonamide
- n-[5-(4,5-dihydro-1h-imidazol-2yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulphonamide
Look up A61603 in the interactive SynDRA portal →